BioXcel Therapeutics Announces BXCL501 Program Initiative for Prevention and Treatment of Acute Agitation using Wearable Digital Devices

September 18, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search